Pertussis (Whooping Cough) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2000

Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red, watery eyes, and dry cough. Treatment includes antibiotics.

The Pertussis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Pertussis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report offers an overview of key players involved in therapeutic development for Pertussis and features dormant and discontinued projects.

Pertussis Pipeline Drugs Market Segmentation by Targets

Some of the targets of the Pertussis pipeline drugs market are Pertussis Toxin, Diphtheria Toxin, Tetanus Toxin, Haemophilus influenzae Lipooligosaccharide, and Others. Pertussis Toxin leads this segment of the Pertussis pipeline drugs market.

Pertussis Pipeline Drugs Market Analysis, by Targets

Pertussis Pipeline Drugs Market Analysis, by TargetsFor more Pertussis pipeline drugs market target insights, download a free report sample

Pertussis Pipeline Drugs Market Segmentation by Mechanisms of Action

Some of the key mechanisms of action of the Pertussis pipeline drugs market are Bordetella pertussis Pertussis Toxin S1 Subunit Inhibitor and Pertussis Toxin Inhibitor. Both MoA are at par in the Pertussis pipeline drugs market in terms of MoA.

Pertussis Pipeline Drugs Market Analysis, by Mechanisms of Action

Pertussis Pipeline Drugs Market Analysis, by Mechanisms of Action

 For more mechanisms of action insights into the Pertussis pipeline drugs market, download a free report sample

Pertussis Pipeline Drugs Market Segmentation by Routes of Administration

The key routes of administration in the Pertussis pipeline drugs market are intramuscular, nasal, subcutaneous, and oral. Intramuscular leads the Pertussis pipeline drugs market in terms of RoA.

Pertussis Pipeline Drugs Market Analysis, by Routes of Administration

Pertussis Pipeline Drugs Market Analysis, by Routes of AdministrationFor more routes of administration insights into the Pertussis pipeline drugs market, download a free report sample

Pertussis Pipeline Drugs Market Segmentation by Molecule Types

The molecule types in the Pertussis pipeline drugs market are toxoid vaccine, inactivated vaccine, subunit vaccine, vaccine, and others. Toxoid Vaccine leads the Pertussis pipeline drugs market in terms of molecule types.

Pertussis Pipeline Drugs Market Analysis, by Molecule Types

Pertussis Pipeline Drugs Market Analysis, by Molecule TypesFor more molecule-type insights into the Pertussis pipeline drugs market, download a free report sample

Pertussis Pipeline Drugs Market - Competitive Landscape

Some of the key companies in the Pertussis pipeline drugs market are CanSino Biologics Inc, AIM Vaccine Co Ltd, KM Biologics Co Ltd, Serum Institute of India Pvt Ltd, and Others. CanSino Biologics Inc has the highest number of products under development.

Pertussis Pipeline Drugs Market Analysis, by Companies

Pertussis Pipeline Drugs Market Analysis, by CompaniesTo know more about the Pertussis pipeline drugs market companies, download a free report sample

Pertussis Pipeline Drugs Market Report Overview

Key Targets Pertussis Toxin, Diphtheria Toxin, Tetanus Toxin, Haemophilus influenzae Lipooligosaccharide, and Others
Key Mechanisms of Action Bordetella pertussis Pertussis Toxin S1 Subunit Inhibitor and Pertussis Toxin Inhibitor
Key Routes of Administration Intramuscular, Nasal, Subcutaneous, and Oral
Key Molecule Types Toxoid Vaccine, Inactivated Vaccine, Subunit Vaccine, Vaccine, and Others
Key Companies CanSino Biologics Inc, AIM Vaccine Co Ltd, KM Biologics Co Ltd, Serum Institute of India Pvt Ltd, and Others

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Pertussis.
  • The pipeline guide reviews pipeline therapeutics for Pertussis by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Pertussis therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Pertussis therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews the latest news related to pipeline therapeutics for Pertussis

Reasons to Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Pertussis.
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding the Pertussis pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understanding from the know-how what drove them from the pipeline.

AIM Vaccine Co Ltd
Beijing Minhai Biotechnology Co Ltd
Beijing Tiantan Biological Products Co Ltd
Bharat Biotech Ltd
Biken Co Ltd
Biological E Ltd
BioNet-Asia Co Ltd
Boryung Pharmaceutical Co Ltd
CanSino Biologics Inc
Changchun Bcht Biotechnology Co Ltd
Chengdu Olymvax Biopharmaceuticals Inc
Chongqing Zhifei Biological Products Co Ltd
Gamaleya Federal Research Center of Epidemiology and Microbiology
GC Biopharma Corp
GSK plc
ILiAD Biotechnologies LLC
Intravacc BV
KM Biologics Co Ltd
LG Chem Ltd
Novo Medi Sciences Pvt Ltd
Panacea Biotec Ltd
Sanofi
Serum Institute of India Pvt Ltd
Shantha Biotechnics Pvt Ltd
Suzhou Weichao Biotechnology Co Ltd
Theriva Biologics Inc
VaxForm LLC
Wuhan Institute of Biological Products Co Ltd
Yunnan Watson Biotechnology Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Pertussis (Whooping Cough) – Overview

Pertussis (Whooping Cough) – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Pertussis (Whooping Cough) – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Pertussis (Whooping Cough) – Companies Involved in Therapeutics Development

Pertussis (Whooping Cough) – Drug Profiles

Pertussis (Whooping Cough) – Dormant Projects

Pertussis (Whooping Cough) – Discontinued Products

Pertussis (Whooping Cough) – Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Table

List of Tables

Number of Products under Development for Pertussis (Whooping Cough), 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Companies, 2022 (Contd..1)

Number of Products under Development by Universities/Institutes, 2022

Products under Development by Companies, 2022

Products under Development by Companies, 2022 (Contd..1)

Products under Development by Companies, 2022 (Contd..2)

Products under Development by Universities/Institutes, 2022

Number of Products by Stage and Target, 2022

Number of Products by Stage and Mechanism of Action, 2022

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Pertussis (Whooping Cough) – Pipeline by AIM Vaccine Co Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Beijing Minhai Biotechnology Co Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Beijing Tiantan Biological Products Co Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Bharat Biotech Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Biken Co Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Biological E Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by BioNet-Asia Co Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Boryung Pharmaceutical Co Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by CanSino Biologics Inc, 2022

Pertussis (Whooping Cough) – Pipeline by Changchun Bcht Biotechnology Co Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Chengdu Olymvax Biopharmaceuticals Inc, 2022

Pertussis (Whooping Cough) – Pipeline by Chongqing Zhifei Biological Products Co Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Gamaleya Federal Research Center of Epidemiology and Microbiology, 2022

Pertussis (Whooping Cough) – Pipeline by GC Biopharma Corp, 2022

Pertussis (Whooping Cough) – Pipeline by GSK plc, 2022

Pertussis (Whooping Cough) – Pipeline by ILiAD Biotechnologies LLC, 2022

Pertussis (Whooping Cough) – Pipeline by Intravacc BV, 2022

Pertussis (Whooping Cough) – Pipeline by KM Biologics Co Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by LG Chem Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Novo Medi Sciences Pvt Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Panacea Biotec Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Sanofi, 2022

Pertussis (Whooping Cough) – Pipeline by Serum Institute of India Pvt Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Shantha Biotechnics Pvt Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Suzhou Weichao Biotechnology Co Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Theriva Biologics Inc, 2022

Pertussis (Whooping Cough) – Pipeline by VaxForm LLC, 2022

Pertussis (Whooping Cough) – Pipeline by Wuhan Institute of Biological Products Co Ltd, 2022

Pertussis (Whooping Cough) – Pipeline by Yunnan Watson Biotechnology Co Ltd, 2022

Pertussis (Whooping Cough) – Dormant Projects, 2022

Pertussis (Whooping Cough) – Dormant Projects, 2022 (Contd..1)

Pertussis (Whooping Cough) – Dormant Projects, 2022 (Contd..2)

Pertussis (Whooping Cough) – Discontinued Products, 2022

Figures

List of Figures

Number of Products under Development for Pertussis (Whooping Cough), 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Universities/Institutes, 2022

Number of Products by Top 10 Targets, 2022

Number of Products by Stage and Top 10 Targets, 2022

Number of Products by Top 10 Mechanism of Actions, 2022

Number of Products by Stage and Top 10 Mechanism of Actions, 2022

Number of Products by Top 10 Routes of Administration, 2022

Number of Products by Stage and Top 10 Routes of Administration, 2022

Number of Products by Top 10 Molecule Types, 2022

Number of Products by Stage and Top 10 Molecule Types, 2022

Frequently asked questions

Pertussis (Whooping Cough) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update thematic reports
Currency USD
$2,000

Can be used by individual purchaser only

$6,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Pertussis (Whooping Cough) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update in real time.

  • Access a live Pertussis (Whooping Cough) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.